Hennion & Walsh Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Hennion & Walsh Asset Management's PFE Position: Q1 2026 in Review
Hennion & Walsh Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 12,591 shares — an estimated $314K sold.
Hennion & Walsh Asset Management first reported a position in PFE in Q1 2021 and held it in 20 quarters. The position peaked at $3.93M in Q1 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Hennion & Walsh Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Hennion & Walsh Asset Management sold 12,591 Pfizer shares in Q1 2026, an estimated $314K.
- Hennion & Walsh Asset Management first reported a position in Pfizer in Q1 2021 and held it in 20 quarters.
- Hennion & Walsh Asset Management's Pfizer position peaked at $3.93M in Q1 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Hennion & Walsh Asset Management's 13F filing for Q1 2026, filed 13 May 2026.